ISDA

Deposition Date 2013-12-14

Release Date 2014-02-12

Last Version Date 2024-11-27

Entry Detail

PDB ID:

4O0Y

Keywords:

transferase/transferase inhibitor

Title:

Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.20 Å

R-Value Free:

0.23

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Serine/threonine-protein kinase PAK 4
Gene (Uniprot):PAK4
Chain IDs:A
Chain Length:293
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:O96013 Pfam ID:PF00069 EC:2.7.11.1

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
SEP	A	SER	PHOSPHOSERINE

Ligand Molecules

2OO

Primary Citation

Back Pocket Flexibility Provides Group II p21-Activated Kinase (PAK) Selectivity for Type I 1/2 Kinase Inhibitors.

Staben, S.T, Feng, J.A, Lyle, K, Belvin, M, Boggs, J, Burch, J.D, Chua, C.C, Cui, H, Dipasquale, A.G, Friedman, L.S, Heise, C, Koeppen, H, Kotey, A, Mintzer, R, Oh, A, Roberts, D.A, Rouge, L, Rudolph, J, Tam, C, Wang, W, Xiao, Y, Young, A, Zhang, Y, Hoeflich, K.P.Show

J.Med.Chem. 57 1033 1045 (2014)

PMID: 24432870 DOI: 10.1021/jm401768t

Abstact

Structure-based methods were used to design a potent and highly selective group II p21-activated kinase (PAK) inhibitor with a novel binding mode, compound 17. Hydrophobic interactions within a lipophilic pocket past the methionine gatekeeper of group II PAKs approached by these type I 1/2 binders were found to be important for improving potency. A structure-based hypothesis and strategy for achieving selectivity over group I PAKs, and the broad kinome, based on unique flexibility of this lipophilic pocket, is presented. A concentration-dependent decrease in tumor cell migration and invasion in two triple-negative breast cancer cell lines was observed with compound 17.

Legend

Protein

Chemical

Disease

Primary Citation of related structures